Regarding tumoral contexts, we have also uncovered a critical functional contribution of SOS1 for development of DMBA/TPA-induced skin carcinogenesis32 and BCR/ABL-driven chronic myeloid leukemia33,34, thus supporting the consideration of this GEF isoform as a potentially useful therapeutic target for RAS-dependent cancers. Here, SOS1 is linked to cancer.